학술논문

COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children
Document Type
Article
Author
Blanchard-Rohner, GeraldineSanchez, CarlosAndre, Maya C.Bressieux-Degueldre, SabrinaGrazioli, SergePerez, Marie-HeleneWütz, DanielaSchöbi, NinaWelzel, TatjanaAtkinson, AndrewSchlapbach, Luregn J.Bielicki, Julia A.Trück, JohannesKoehler, HenrikGysi, SpyridoulaJanz, IndraBieri, AndreasDonner, BirgitHammer, JürgHeininger, Ulrichvon Kalckreuth, ClemensKohns, MalteMettauer, NicoleMeyer, AlexandraReppucci, DianaSchlaeppi, ChloéTrachsel, DanielVaezipour, NinaWoerner, AndreasZutter, AndreasVanoni, FedericaKottanattu, LisaMazzara, CalogeroSeveri Conti, AlessiaAebi, ChristophAgyeman, PhilippDuppenthaler, AndreaGlöckler, MartinPallivathukal, SabineRiedel, ThomasZimmermann, PetraCudré-Cung, Hong-PhucPavlovic, MladenBordessoule, AliceMartin, Anne-LaurePolito, AngeloWagner, NoemieRohr, MarieL’Huillier, ArnaudAmiet, VivianneFerry, ThomasLongchamp, DavidNatterer, JuliaOppenheim, RebeccaHofer, MichaelBuettcher, MichaelWechselberger, KatharinaDonas, AlexGermann, SaraLütolf Erni, MichaelaKaiser, DanielaSchwendener Scholl, KatharinaPeter Kuen, HansHrup, KatjaStritt, JanineBailey, Douggl G. N.Wachinger, TanjaBeck, IngridBirkenmaier, AndréRogdo, BjarteLorenz, PhilipIglowstein, IvoZöhrer, KonstanzeFlade, MartinPrader, SerainaPachlopnik Schmid, JanaSeiler, MichelleMeyer Sauteur, PatrickBrotschi, BarbaraWeber, KathrinWhittaker, ElizabethFaust, Saul N.
Source
The Pediatric Infectious Disease Journal; April 2024, Vol. 43 Issue: 4 p361-364, 4p
Subject
Language
ISSN
08913668; 15320987
Abstract
Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT 04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.